课题基金 / 基金详情

Canadian Cohort Obstructive Lung Disease (CanCOLD)

Canadian Cohort Obstructive Lung Disease (CanCOLD)
加拿大队列阻塞性肺病 (CanCOLD)
批准号：
221591
负责人：
Bourbeau Jean
金额：
$76.59万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-09-01 至 2013-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=221591&lang=en
关键词：
Chronic Obstructive Pulmonary Disease Cohort Study Copd Prospective Longitudinal Study Tissue Bank

项目摘要

项目成果

Bourbeau Jean的其他基金

相似基金

相关文献

中文摘要
翻译
慢性阻塞性肺疾病（COPD）是加拿大第四大死因。慢性阻塞性肺病是慢性支气管炎和肺气肿的总称，由于缺乏对这些疾病的了解，患有慢性阻塞性肺病的人往往得不到所需的护理
英文摘要
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in Canada. People with COPD, the umbrella term for chronic bronchitis and emphysema, often don't get the care they need because of a lack of knowledge of the diseases among
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum
Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum
Air pollution, climate and COPD: acute and long-term impacts in Canadian populations
COVID-19 and COPD: Important knowledge gaps in subclinical pulmonary disease in the Canadian population
海外基金